Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large observational cohort
Assessing the clinical impact of lost T-cell homeostasis on AIDS-defining illnesses or death
View PublicationFilter By:
A marginal structural model for multiple‐outcome survival data:assessing the impact of injection drug use on several causes of death in the Canadian Co‐infection Cohort
Developing a marginal structural model that permits estimation of cause‐specific hazards in situations where more than one cause of death is of interest
View PublicationModeling the impact of hepatitis C viral clearance on end‐stage liver disease in an HIV co‐infected cohort with targeted maximum likelihood estimation
Demonstrating the double‐robust and semiparametric efficient method of Targeted Maximum Likelihood Estimation
View PublicationDemographic and clinical factors correlating with high levels of psychological distress in HIV-positive women living in Ontario, Canada
Determining the prevalence, severity, and correlates of psychological distress among women accessing HIV care participating in the Ontario HIV Treatment Network Cohort Study
View PublicationCharacteristics and determinants of T ‐cell phenotype normalization in HIV ‐1‐infected individuals receiving long‐term antiretroviral therapy
Assessing the incidence and predictors of reversing alterations in T ‐cell regulation and homeostasis with cART
View PublicationPredictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy
Examining the predictors of CD4:CD8 normalization after cART and determining whether normalization is associated with reduced progression to AIDS-defining illnesses and death
View PublicationVariation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort study
Exploring the uptake of HCV treatment to determine if some treatment centres have been more successful than others at starting patients with HIV–HCV coinfection on HCV treatment
View PublicationMarijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis
Estimating the effect of marijuana smoking on liver disease progression in HIV/HCV-coinfected persons
View PublicationA Randomized Controlled Pilot Trial of Valacyclovir for Attenuating Inflammation and Immune Activation in HIV/Herpes Simplex Virus 2–Coinfected Adults on Suppressive Antiretroviral Therapy
Investigating how valacyclovir affects systemic immune activation or inflammatory biomarkers in HIV-1/HSV-2–coinfected adults on suppressive ART
View Publication